Boehringer Ingelheim - Interferon Gamma-1b - Ownership and Business Overview

Life ScienceCompany

Boehringer Ingelheim - Interferon Gamma-1b Ownership

Who owns Boehringer Ingelheim - Interferon Gamma-1b?

Boehringer Ingelheim - Interferon Gamma-1b is owned by Horizon Therapeutics Public Limited Company. It was acquired on May 19, 2016.

Boehringer Ingelheim - Interferon Gamma-1b Business Overview

Where is Boehringer Ingelheim - Interferon Gamma-1b headquartered?

Boehringer Ingelheim - Interferon Gamma-1b is headquartered in Germany.

What sector is Boehringer Ingelheim - Interferon Gamma-1b in?

Boehringer Ingelheim - Interferon Gamma-1b is a life science company.

Life Science M&A Summary in 2016

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2016. The largest life science acquisition in 2016 was Baxalta - which was acquired by Shire for $32.0B.

Join Mergr to view all 292 acquisitions of life science companies in 2016, including 31 acquisitions by private equity firms, and 261 by strategics.

Boehringer Ingelheim - Interferon Gamma-1b


Germany,

Boehringer Ingelheim - Interferon Gamma-1b comprises rights to manufacture the pharmaceutical Interferon Gamma-1b, which Boehringer Ingelheim commercializes under the trade names IMUKIN, IMUKINE, IMMUKIN and IMMUKINE in an estimated 30 countries primarily in Europe and the Middle East.


Company Summary

SECTOR

Life Science

 Subscribe to unlock this and 201,535
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Boehringer Ingelheim - Interferon Gamma-1b

Life Science Companies , Germany Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for Germany Companies

Largest Germany Companies , Acquisitive Germany Companies , Recently Acquired Germany Companies , Recently Sold Germany Companies , Private Germany Companies , Public Germany Companies , Acquired Germany Companies , PE Backed Germany Companies
Mergr

Product

Company

Legal